271 related articles for article (PubMed ID: 18208603)
1. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
2. Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.
Lin SF; Wei H; Maeder D; Franklin RB; Feng P
J Nutr Biochem; 2009 Dec; 20(12):1000-12. PubMed ID: 19071009
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
4. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein expression in human prostate gland.
Bataineh ZM; Nusier MK
Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
[TBL] [Abstract][Full Text] [Related]
6. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
Yin H; Smith M; Glass J
Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
9. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues.
Hasumi M; Suzuki K; Matsui H; Koike H; Ito K; Yamanaka H
Cancer Lett; 2003 Oct; 200(2):187-95. PubMed ID: 14568174
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer.
Garrett SH; Sens MA; Shukla D; Flores L; Somji S; Todd JH; Sens DA
Prostate; 2000 May; 43(2):125-35. PubMed ID: 10754528
[TBL] [Abstract][Full Text] [Related]
11. HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.
Monsef N; Soller M; Panagopoulos I; Abrahamsson PA
BMC Cancer; 2010 Jul; 10():385. PubMed ID: 20663134
[TBL] [Abstract][Full Text] [Related]
12. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
Sroka IC; McDaniel K; Nagle RB; Bowden GT
Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.
Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
Int J Oncol; 1998 Nov; 13(5):927-34. PubMed ID: 9772281
[TBL] [Abstract][Full Text] [Related]
15. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
[TBL] [Abstract][Full Text] [Related]
16. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
[TBL] [Abstract][Full Text] [Related]
17. Expression of Metallothionein and Vascular Endothelial Growth Factor Isoforms in Breast Cancer Cells.
Wierzowiecka B; Gomulkiewicz A; Cwynar-Zajac L; Olbromski M; Grzegrzolka J; Kobierzycki C; Podhorska-Okolow M; Dziegiel P
In Vivo; 2016; 30(3):271-8. PubMed ID: 27107086
[TBL] [Abstract][Full Text] [Related]
18. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines.
Tekur S; Ho SM
Mol Carcinog; 2002 Jan; 33(1):44-55. PubMed ID: 11807957
[TBL] [Abstract][Full Text] [Related]
19. Differential response to zinc-induced apoptosis in benign prostate hyperplasia and prostate cancer cells.
Yan M; Hardin K; Ho E
J Nutr Biochem; 2010 Aug; 21(8):687-94. PubMed ID: 19576751
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.
Handisurya A; Steiner GE; Stix U; Ecker RC; Pfaffeneder-Mantai S; Langer D; Kramer G; Memaran-Dadgar N; Marberger M
Prostate; 2001 Dec; 49(4):251-62. PubMed ID: 11746271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
